Home › Peanut Hypersensitivity › New York
Peanut Hypersensitivity clinical trials in New York
5 studies for Peanut Hypersensitivity are looking for participants at sites in New York.
Cities in New York
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
- Northwell Health, New York
- Montefiore Health System, The Bronx
RecruitingPhase 3
Ages 12 to 65 · All sexes · Updated Sep 25, 2026 · NCT07768371Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Sep 16, 2026 · NCT07015996Study of Oral Food Challenge Biomarkers (SAFER)
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
RecruitingObservational study
12 Months – 17 Years · All sexes · Updated Sep 9, 2026 · NCT07279467Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- Northwell Health, Great Neck
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Jul 28, 2026 · NCT07220811Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg
- University of Rochester, Rochester
RecruitingHealthy volunteers welcome
1 Day · Women · Updated Jul 20, 2026 · NCT06260956From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.